Charles Schwab
IBIO icon

Charles Schwab’s iBio IBIO Stock Holding History

Charles Schwab’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-362
Closed -$31K – 3555
2022
Q3 		$31K Buy
+362
New +$49.8K ﹤0.01% 3424
2022
Q2 		– Sell
-1,172
Closed -$252K – 3589
2022
Q1 		$252K Buy
1,172
+108
+10% +$22.6K ﹤0.01% 3269
2021
Q4 		$293K Hold
1,064
– – ﹤0.01% 3291
2021
Q3 		$565K Hold
1,064
– – ﹤0.01% 3106
2021
Q2 		$804K Buy
1,064
+4
+0.4% +$2.92K ﹤0.01% 3003
2021
Q1 		$817K Buy
1,060
+161
+18% +$140K ﹤0.01% 2918
2020
Q4 		$473K Buy
899
+511
+132% +$416K ﹤0.01% 3009
2020
Q3 		$394K Buy
388
+104
+37% +$151K ﹤0.01% 2952
2020
Q2 		$316K Buy
+284
New +$186K ﹤0.01% 3018

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return